China confronts senior cancer surge with early detection, TCM
With a rapidly aging population, China is facing a pressing new public health challenge: cancer among the elderly. According to the latest data, people over the age of 60 now…
With a rapidly aging population, China is facing a pressing new public health challenge: cancer among the elderly. According to the latest data, people over the age of 60 now…
The Nuclear Medicine Oncology and Radiotherapy Institute (NORI) has got the cyclotron, worth Rs1.5 billion, due to which Gallium 68-related isotope radiation for positron emission tomography (PET) scans has become…
China’s five-year cancer survival rate has steadily improved. Still, challenges remain as the country strives to address regional disparities in access to quality cancer prevention and treatment. The percentage of…